Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc., No. 23-2218 (Fed. Cir. 2025) — On January 10, 2025, the Federal Circuit reversed ...

WASHINGTON, Jan 17 (Reuters) - The Federal Trade Commission on Friday said it has reached a settlement with Welsh, Carson, Anderson & Stowe and its affiliates in a case that accused the private ...

Hikma Pharmaceuticals in the US joined government officials and non-profit leaders today at a naloxone awareness and training event organized and hosted by Rep. Earl L. "Buddy" Carter of Georgia.

At the 2025 JP Morgan Healthcare Conference, GoodRx’s recently appointed CEO Wendy Barnes highlighted the company’s strategic position to address the gaps in the US healthcare landscape. Referring to ...

It's no secret that the US government is very nosy, and undertakes a ton of surveillance on its citizens. Due to that, there's huge demand for the best US VPNs. Using a VPN in the US encrypts your ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Charlotte's business landscape is set to enrich further with groninger USA, LLC choosing the city for its manufacturing operations expansion. The company, a leader in the pharmaceutical ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...

Credit: Jonathan Weiss / Shutterstock. This January, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US, according to data from healthcare research ...